Vaccination strategies for mucosal immune responses

Area of Science:

• Immunology
• Vaccinology
• Mucosal Immunity

Background:

• Mucosal administration of vaccines is crucial for inducing immune responses at systemic and mucosal sites.
• Induction of immune responses and oral tolerance involves complex immunological events like T-cell activation and cytokine expression.
• Current infant vaccination involves multiple percutaneous injections, highlighting the need for alternative delivery methods.

Purpose of the Study:

• To explore mucosal vaccines as a painless and effective immunization strategy.
• To discuss the potential of mucosal vaccines in preventing infections and inducing systemic tolerance.
• To highlight the role of mucosal immunity in controlling infectious and autoimmune diseases.

Main Methods:

• Review of existing knowledge on mucosal immune responses and tolerance induction.
• Discussion of various vaccine platforms for mucosal delivery (recombinant, transgenic, vector-based, plant-based).
• Exploration of manipulating the mucosal immune system for therapeutic purposes.

Main Results:

• Mucosal vaccines can induce specific antibody- or T-cell-mediated immune responses.
• Mucosal immunization can lead to systemic immunologic hyporesponsiveness (oral tolerance).
• Development of effective, nonliving, and diverse mucosal vaccine types is feasible.

Conclusions:

• Mucosal vaccines present a painless and efficient method for immunization, potentially reducing the number of injections.
• This approach can be utilized to prevent various infections.
• Mucosal immunity offers novel strategies for the prophylactic and therapeutic control of autoimmune diseases.